| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 9.52e-07 | 9 | 46 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 9.52e-07 | 9 | 46 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.75e-06 | 46 | 46 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.09e-06 | 14 | 46 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.55e-05 | 152 | 46 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 3.11e-05 | 4 | 46 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.03e-05 | 182 | 46 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.35e-05 | 184 | 46 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.29e-04 | 343 | 46 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.20e-04 | 129 | 46 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.01e-04 | 151 | 46 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.14e-04 | 459 | 46 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.57e-04 | 465 | 46 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.93e-04 | 334 | 46 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HELZ2 FGA NIPSNAP2 NANOGP8 TIAL1 NANOG HNRNPU NIPSNAP1 TNRC6A | 1.15e-03 | 1160 | 46 | 9 | GO:0030674 |
| GeneOntologyMolecularFunction | channel activity | 1.23e-03 | 525 | 46 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.24e-03 | 526 | 46 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.52e-03 | 749 | 46 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.92e-03 | 230 | 46 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 2.03e-03 | 29 | 46 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | poly(A) binding | 2.03e-03 | 29 | 46 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.17e-03 | 30 | 46 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.31e-03 | 31 | 46 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.01e-03 | 627 | 46 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 3.28e-03 | 37 | 46 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | HELZ2 FGA NIPSNAP2 NANOGP8 TIAL1 NANOG HNRNPU NIPSNAP1 TNRC6A | 3.35e-03 | 1356 | 46 | 9 | GO:0060090 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.99e-03 | 664 | 46 | 6 | GO:0008324 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 2.78e-05 | 4 | 45 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 4.63e-05 | 5 | 45 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 5.06e-05 | 33 | 45 | 3 | GO:2000737 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 6.94e-05 | 6 | 45 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 1.27e-04 | 118 | 45 | 4 | GO:0046928 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 1.29e-04 | 8 | 45 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.57e-04 | 48 | 45 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.57e-04 | 48 | 45 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.58e-04 | 125 | 45 | 4 | GO:0016079 | |
| GeneOntologyBiologicalProcess | stem cell division | 1.67e-04 | 49 | 45 | 3 | GO:0017145 | |
| GeneOntologyBiologicalProcess | response to pain | 1.88e-04 | 51 | 45 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 1.95e-04 | 132 | 45 | 4 | GO:0000956 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 2.07e-04 | 10 | 45 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.51e-04 | 141 | 45 | 4 | GO:0051588 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 2.53e-04 | 11 | 45 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.58e-04 | 142 | 45 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.58e-04 | 142 | 45 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 2.66e-04 | 264 | 45 | 5 | GO:0099504 | |
| GeneOntologyBiologicalProcess | exocytosis | 3.41e-04 | 434 | 45 | 6 | GO:0006887 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.86e-04 | 65 | 45 | 3 | GO:0000288 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 4.17e-04 | 14 | 45 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 4.80e-04 | 15 | 45 | 2 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 4.80e-04 | 15 | 45 | 2 | GO:0043696 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell proliferation | 5.21e-04 | 72 | 45 | 3 | GO:2000648 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.48e-04 | 16 | 45 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 6.20e-04 | 17 | 45 | 2 | GO:0010454 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 6.49e-04 | 321 | 45 | 5 | GO:0099003 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 6.96e-04 | 18 | 45 | 2 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 6.96e-04 | 18 | 45 | 2 | GO:2000035 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 7.89e-04 | 509 | 45 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 8.52e-04 | 195 | 45 | 4 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 8.52e-04 | 195 | 45 | 4 | GO:0007269 | |
| GeneOntologyBiologicalProcess | endoderm development | 9.35e-04 | 88 | 45 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 1.14e-03 | 23 | 45 | 2 | GO:0001710 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.88e-06 | 269 | 46 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.89e-06 | 287 | 46 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.13e-06 | 46 | 46 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.00e-05 | 73 | 46 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | 1.62e-04 | 235 | 46 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.71e-04 | 378 | 46 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | cell surface | 6.08e-04 | 1111 | 46 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 9.55e-04 | 523 | 46 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.24e-03 | 550 | 46 | 6 | GO:1990351 | |
| MousePheno | abnormal respiration | 3.02e-05 | 598 | 39 | 9 | MP:0001943 | |
| MousePheno | abnormal muscle electrophysiology | 9.42e-05 | 32 | 39 | 3 | MP:0004145 | |
| MousePheno | abnormal channel response | 1.03e-04 | 33 | 39 | 3 | MP:0003484 | |
| MousePheno | increased total lung capacity | 1.58e-04 | 7 | 39 | 2 | MP:0010937 | |
| Domain | VDCC_a1su_IQ | 4.54e-07 | 7 | 45 | 3 | IPR014873 | |
| Domain | GPHH | 4.54e-07 | 7 | 45 | 3 | PF16905 | |
| Domain | GPHH_dom | 4.54e-07 | 7 | 45 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.54e-07 | 7 | 45 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 4.54e-07 | 7 | 45 | 3 | PF08763 | |
| Domain | VDCCAlpha1 | 1.55e-06 | 10 | 45 | 3 | IPR002077 | |
| Domain | Ion_trans_dom | 7.80e-06 | 114 | 45 | 5 | IPR005821 | |
| Domain | Ion_trans | 7.80e-06 | 114 | 45 | 5 | PF00520 | |
| Domain | Channel_four-helix_dom | 1.06e-05 | 57 | 45 | 4 | IPR027359 | |
| Domain | - | 1.06e-05 | 57 | 45 | 4 | 1.20.120.350 | |
| Domain | Ago_hook | 1.70e-05 | 3 | 45 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.70e-05 | 3 | 45 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.70e-05 | 3 | 45 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.70e-05 | 3 | 45 | 2 | PF16608 | |
| Domain | NIPSNAP | 3.40e-05 | 4 | 45 | 2 | IPR012577 | |
| Domain | NIPSNAP | 3.40e-05 | 4 | 45 | 2 | PF07978 | |
| Domain | Dimeric_a/b-barrel | 1.18e-04 | 7 | 45 | 2 | IPR011008 | |
| Domain | RRM_dom_euk | 1.39e-03 | 23 | 45 | 2 | IPR003954 | |
| Domain | RRM_1 | 1.39e-03 | 23 | 45 | 2 | SM00361 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.51e-03 | 24 | 45 | 2 | IPR014715 | |
| Domain | - | 1.51e-03 | 24 | 45 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_C | 1.92e-03 | 27 | 45 | 2 | PF00147 | |
| Domain | FBG | 2.21e-03 | 29 | 45 | 2 | SM00186 | |
| Domain | RRM | 2.25e-03 | 230 | 45 | 4 | PS50102 | |
| Domain | - | 2.37e-03 | 30 | 45 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.37e-03 | 30 | 45 | 2 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 2.69e-03 | 32 | 45 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.69e-03 | 32 | 45 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.69e-03 | 32 | 45 | 2 | PS51406 | |
| Domain | - | 2.78e-03 | 244 | 45 | 4 | 3.30.70.330 | |
| Domain | GPS | 3.03e-03 | 34 | 45 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 3.03e-03 | 34 | 45 | 2 | IPR017983 | |
| Domain | GPS | 3.21e-03 | 35 | 45 | 2 | PF01825 | |
| Domain | GPS | 3.39e-03 | 36 | 45 | 2 | PS50221 | |
| Domain | Nucleotide-bd_a/b_plait | 3.40e-03 | 258 | 45 | 4 | IPR012677 | |
| Domain | GPS | 3.58e-03 | 37 | 45 | 2 | IPR000203 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.18e-03 | 40 | 45 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 4.18e-03 | 40 | 45 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.18e-03 | 40 | 45 | 2 | PS50227 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.46e-03 | 50 | 45 | 2 | PS00650 | |
| Domain | 7tm_2 | 6.46e-03 | 50 | 45 | 2 | PF00002 | |
| Domain | Homeodomain-like | 8.24e-03 | 332 | 45 | 4 | IPR009057 | |
| Domain | GPCR_2_secretin-like | 9.19e-03 | 60 | 45 | 2 | IPR000832 | |
| Domain | GPCR_2-like | 9.19e-03 | 60 | 45 | 2 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 9.49e-03 | 61 | 45 | 2 | PS50261 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.00e-08 | 11 | 41 | 4 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.71e-06 | 11 | 41 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.71e-06 | 11 | 41 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.88e-05 | 23 | 41 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.02e-05 | 25 | 41 | 3 | M47948 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.23e-04 | 6 | 41 | 2 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.72e-04 | 7 | 41 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.93e-04 | 9 | 41 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.93e-04 | 9 | 41 | 2 | M46436 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.39e-04 | 47 | 41 | 3 | M19708 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 3.66e-04 | 10 | 41 | 2 | M48013 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 4.32e-04 | 51 | 41 | 3 | M39457 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 6.31e-04 | 13 | 41 | 2 | M46434 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 8.52e-04 | 147 | 41 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.41e-04 | 151 | 41 | 4 | M39329 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.09e-03 | 17 | 41 | 2 | M27788 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.28e-03 | 74 | 41 | 3 | M48080 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.37e-03 | 19 | 41 | 2 | M48238 | |
| Pathway | WP_GPCRS_ORPHAN | 1.37e-03 | 19 | 41 | 2 | MM15991 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.73e-03 | 178 | 41 | 4 | M2890 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 2.17e-09 | 3 | 46 | 3 | 24523520 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 8.65e-09 | 4 | 46 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 8.65e-09 | 4 | 46 | 3 | 37141091 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 8825650 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 15451373 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 12855701 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 11296258 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 4.32e-08 | 6 | 46 | 3 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 4.32e-08 | 6 | 46 | 3 | 12827191 | |
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 9238069 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 7.55e-08 | 7 | 46 | 3 | 35176221 | |
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 16382099 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.91e-07 | 38 | 46 | 4 | 30786075 | |
| Pubmed | 9.74e-07 | 15 | 46 | 3 | 20188150 | ||
| Pubmed | 9.74e-07 | 15 | 46 | 3 | 24453333 | ||
| Pubmed | RBM19 is essential for preimplantation development in the mouse. | 9.74e-07 | 15 | 46 | 3 | 19087264 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 9.87e-07 | 135 | 46 | 5 | 31077711 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.14e-06 | 139 | 46 | 5 | 16985003 | |
| Pubmed | The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse. | 1.20e-06 | 16 | 46 | 3 | 23463509 | |
| Pubmed | iCLIP predicts the dual splicing effects of TIA-RNA interactions. | 1.71e-06 | 2 | 46 | 2 | 21048981 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20675271 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11514562 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29791863 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.71e-06 | 2 | 46 | 2 | 23426690 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17488725 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16381801 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 23054835 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24696465 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24086455 | ||
| Pubmed | NIPSNAP1 and NIPSNAP2 Act as "Eat Me" Signals for Mitophagy. | 1.71e-06 | 2 | 46 | 2 | 30982665 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27998764 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 1.71e-06 | 2 | 46 | 2 | 19415763 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 23376566 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24927121 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19339348 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 8871565 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24598770 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16278295 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 1.71e-06 | 2 | 46 | 2 | 22079639 | |
| Pubmed | Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. | 1.71e-06 | 2 | 46 | 2 | 8576255 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 38155373 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20980400 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 1.71e-06 | 2 | 46 | 2 | 12074836 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18456862 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15050706 | ||
| Pubmed | Structure of the central RNA recognition motif of human TIA-1 at 1.95A resolution. | 1.71e-06 | 2 | 46 | 2 | 18201561 | |
| Pubmed | TIA-1 and TIAR interact with 5'-UTR of enterovirus 71 genome and facilitate viral replication. | 1.71e-06 | 2 | 46 | 2 | 26363455 | |
| Pubmed | TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. | 1.71e-06 | 2 | 46 | 2 | 10921895 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 1.71e-06 | 2 | 46 | 2 | 21136380 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 1.75e-06 | 639 | 46 | 8 | 23443559 | |
| Pubmed | CACNA1A CACNA1B NIPSNAP2 TNRC6B SCRN1 LRP1B UNC13A HNRNPU NIPSNAP1 TNRC6A | 1.90e-06 | 1139 | 46 | 10 | 36417873 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.83e-06 | 21 | 46 | 3 | 21337463 | |
| Pubmed | A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. | 3.28e-06 | 22 | 46 | 3 | 19483677 | |
| Pubmed | 3.77e-06 | 317 | 46 | 6 | 30997501 | ||
| Pubmed | NIP-SNAP-1 and -2 mitochondrial proteins are maintained by heat shock protein 60. | 5.13e-06 | 3 | 46 | 2 | 28011268 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 5.13e-06 | 3 | 46 | 2 | 30814124 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 5.13e-06 | 3 | 46 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 5.13e-06 | 3 | 46 | 2 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 5.13e-06 | 3 | 46 | 2 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 5.13e-06 | 3 | 46 | 2 | 18177668 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 5.13e-06 | 3 | 46 | 2 | 16259959 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18313230 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 12609610 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 24227785 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 24929238 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 29466725 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 5.13e-06 | 3 | 46 | 2 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 5.13e-06 | 3 | 46 | 2 | 23770853 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 15502159 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 5.13e-06 | 3 | 46 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 5.13e-06 | 3 | 46 | 2 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 5.13e-06 | 3 | 46 | 2 | 24527385 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18086680 | ||
| Pubmed | TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2. | 5.13e-06 | 3 | 46 | 2 | 19110540 | |
| Pubmed | TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy. | 5.13e-06 | 3 | 46 | 2 | 21189287 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 17204467 | ||
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 5.13e-06 | 3 | 46 | 2 | 19800316 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23200040 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 5.13e-06 | 3 | 46 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 5.13e-06 | 3 | 46 | 2 | 23329853 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 5.13e-06 | 3 | 46 | 2 | 24394417 | |
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 5.13e-06 | 3 | 46 | 2 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 5.13e-06 | 3 | 46 | 2 | 17352742 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 5.13e-06 | 3 | 46 | 2 | 25005472 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 16773043 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 5.13e-06 | 3 | 46 | 2 | 26733157 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23071603 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 5.13e-06 | 3 | 46 | 2 | 19582141 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 21119109 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 32145514 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 19703398 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 5.13e-06 | 3 | 46 | 2 | 18097409 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 5.13e-06 | 3 | 46 | 2 | 28636920 | |
| Interaction | MOV10 interactions | NIPSNAP2 TNRC6B SMG1 DFFA SARAF TIAL1 CANT1 FUBP3 UNC13A NANOG HNRNPU NIPSNAP1 B4GALT4 TNRC6A | 3.60e-07 | 1297 | 44 | 14 | int:MOV10 |
| Interaction | TOP3B interactions | HELZ2 KCNK5 TNRC6B ARSJ HERC2 TIA1 ADAMTS7 CANT1 FUBP3 PCNX4 HOXB13 RYR1 HNRNPU NIPSNAP1 | 1.63e-06 | 1470 | 44 | 14 | int:TOP3B |
| Interaction | PABPC1 interactions | 2.02e-06 | 699 | 44 | 10 | int:PABPC1 | |
| Interaction | FAM120C interactions | 3.51e-06 | 191 | 44 | 6 | int:FAM120C | |
| Interaction | HRG interactions | 1.07e-05 | 63 | 44 | 4 | int:HRG | |
| Interaction | YTHDF3 interactions | 1.49e-05 | 246 | 44 | 6 | int:YTHDF3 | |
| Interaction | DAZL interactions | 1.56e-05 | 145 | 44 | 5 | int:DAZL | |
| Interaction | RB1CC1 interactions | 1.89e-05 | 387 | 44 | 7 | int:RB1CC1 | |
| Interaction | CACNB4 interactions | 2.16e-05 | 25 | 44 | 3 | int:CACNB4 | |
| Interaction | TIA1 interactions | 2.79e-05 | 275 | 44 | 6 | int:TIA1 | |
| Interaction | SMG5 interactions | 3.36e-05 | 84 | 44 | 4 | int:SMG5 | |
| Interaction | TIAL1 interactions | 3.54e-05 | 172 | 44 | 5 | int:TIAL1 | |
| Interaction | DDX1 interactions | 5.93e-05 | 463 | 44 | 7 | int:DDX1 | |
| Interaction | NDP interactions | 6.05e-05 | 35 | 44 | 3 | int:NDP | |
| Interaction | TMPRSS13 interactions | 8.35e-05 | 106 | 44 | 4 | int:TMPRSS13 | |
| Interaction | DEFB136 interactions | 1.21e-04 | 44 | 44 | 3 | int:DEFB136 | |
| Interaction | FMR1 interactions | 1.48e-04 | 536 | 44 | 7 | int:FMR1 | |
| Interaction | OTUD4 interactions | 1.58e-04 | 236 | 44 | 5 | int:OTUD4 | |
| Interaction | SOX2 interactions | HELZ2 FGA MFAP4 MFGE8 TIA1 TIAL1 FUBP3 NANOG RYR1 HNRNPU TNRC6A | 1.82e-04 | 1422 | 44 | 11 | int:SOX2 |
| Interaction | PRRC2A interactions | 1.89e-04 | 389 | 44 | 6 | int:PRRC2A | |
| Interaction | UNK interactions | 2.44e-04 | 408 | 44 | 6 | int:UNK | |
| Interaction | LSM14A interactions | 2.48e-04 | 260 | 44 | 5 | int:LSM14A | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.16e-05 | 26 | 31 | 3 | 253 | |
| GeneFamily | Fibrinogen C domain containing | 8.33e-04 | 25 | 31 | 2 | 554 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.33e-04 | 25 | 31 | 2 | 775 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.59e-03 | 161 | 31 | 3 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 4.32e-03 | 193 | 31 | 3 | 594 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 5.87e-03 | 67 | 31 | 2 | 519 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 1.16e-06 | 200 | 45 | 6 | M3378 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 2.83e-05 | 208 | 45 | 5 | M39233 | |
| Coexpression | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN | 2.87e-05 | 5 | 45 | 2 | M1794 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.56e-05 | 505 | 45 | 7 | Arv_SC-H9hpx_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.11e-05 | 510 | 45 | 7 | Arv_SC-hpx_blastocyst_1000_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#5 | 1.28e-04 | 232 | 45 | 5 | Arv_SC-hpx_blastocyst_500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#1 | 1.28e-04 | 232 | 45 | 5 | Arv_SC-H9hpx_500_K1 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.30e-04 | 540 | 45 | 7 | ratio_SC_vs_MESO_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.52e-04 | 554 | 45 | 7 | Arv_SC_fibroblast_1000_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.57e-04 | 557 | 45 | 7 | Arv_SC-HD_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 2.33e-04 | 416 | 45 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 2.58e-04 | 806 | 45 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.82e-04 | 613 | 45 | 7 | ratio_SC_vs_EB_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.85e-04 | 818 | 45 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-07 | 150 | 45 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 167 | 45 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.85e-07 | 170 | 45 | 5 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 179 | 45 | 5 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 185 | 45 | 5 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 1.76e-05 | 154 | 45 | 4 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-05 | 166 | 45 | 4 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.42e-05 | 167 | 45 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 168 | 45 | 4 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 168 | 45 | 4 | 38ba7737ae0afffcbd3aa499403e83c24a922127 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-05 | 169 | 45 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 174 | 45 | 4 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-05 | 177 | 45 | 4 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-05 | 180 | 45 | 4 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-05 | 180 | 45 | 4 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 180 | 45 | 4 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.44e-05 | 195 | 45 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.71e-05 | 198 | 45 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 2.79e-04 | 126 | 45 | 3 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 2.79e-04 | 126 | 45 | 3 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.92e-04 | 128 | 45 | 3 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-04 | 130 | 45 | 3 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.57e-04 | 137 | 45 | 3 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.57e-04 | 137 | 45 | 3 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.72e-04 | 139 | 45 | 3 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 143 | 45 | 3 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 143 | 45 | 3 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 145 | 45 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-04 | 146 | 45 | 3 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.47e-04 | 148 | 45 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 153 | 45 | 3 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.02e-04 | 154 | 45 | 3 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.31e-04 | 157 | 45 | 3 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.51e-04 | 159 | 45 | 3 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.51e-04 | 159 | 45 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 160 | 45 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 160 | 45 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-04 | 162 | 45 | 3 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-04 | 162 | 45 | 3 | f2a87019ff9b466617e90c60d182ab7d14581cc9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.82e-04 | 162 | 45 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-04 | 162 | 45 | 3 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.92e-04 | 163 | 45 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 6.03e-04 | 164 | 45 | 3 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.03e-04 | 164 | 45 | 3 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-04 | 164 | 45 | 3 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-04 | 165 | 45 | 3 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 165 | 45 | 3 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 165 | 45 | 3 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-04 | 166 | 45 | 3 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-04 | 167 | 45 | 3 | 8ec7a98b542b134f48df8fbec351693cc5cfe55c | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-04 | 167 | 45 | 3 | a9f28c4649ce344ae3ba3a3acb58da9c7efad901 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 6.47e-04 | 168 | 45 | 3 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.58e-04 | 169 | 45 | 3 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 169 | 45 | 3 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-04 | 170 | 45 | 3 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-04 | 171 | 45 | 3 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 171 | 45 | 3 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.81e-04 | 171 | 45 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-04 | 172 | 45 | 3 | ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-04 | 172 | 45 | 3 | 3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.92e-04 | 172 | 45 | 3 | a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-04 | 174 | 45 | 3 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 7.28e-04 | 175 | 45 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 175 | 45 | 3 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 7.28e-04 | 175 | 45 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-04 | 176 | 45 | 3 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-04 | 176 | 45 | 3 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.65e-04 | 178 | 45 | 3 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.65e-04 | 178 | 45 | 3 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-04 | 178 | 45 | 3 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-04 | 178 | 45 | 3 | 1802ff1c6cb18ee62cfef7270c0971048fae5315 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-04 | 178 | 45 | 3 | 4368d20130e5a08716564c19470b6014f16902ac | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.65e-04 | 178 | 45 | 3 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 178 | 45 | 3 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.77e-04 | 179 | 45 | 3 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | ec7c38464863ac3744a8d4880f49421914892339 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-04 | 180 | 45 | 3 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-04 | 180 | 45 | 3 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.90e-04 | 180 | 45 | 3 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 7.90e-04 | 180 | 45 | 3 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-04 | 180 | 45 | 3 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-04 | 180 | 45 | 3 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 8.02e-04 | 181 | 45 | 3 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 14faef1dde781d501834379f2a6413e8d6a80b72 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.02e-04 | 181 | 45 | 3 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 8.15e-04 | 182 | 45 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-04 | 182 | 45 | 3 | 0e589bf97d51b4b2f723f8c45853ad81b7ce8778 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-04 | 182 | 45 | 3 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| Drug | AC 110 | 2.88e-08 | 4 | 45 | 3 | CID000022860 | |
| Drug | 3,4-dihydroquinazoline | 1.44e-07 | 6 | 45 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.44e-07 | 6 | 45 | 3 | CID000133976 | |
| Drug | APMPA | 2.51e-07 | 7 | 45 | 3 | CID000512300 | |
| Drug | CNS 1145 | 5.22e-07 | 33 | 45 | 4 | CID000190902 | |
| Drug | IHC-64 | 5.22e-07 | 33 | 45 | 4 | CID000162753 | |
| Drug | riluzole | 1.16e-06 | 174 | 45 | 6 | CID000005070 | |
| Drug | leys | 1.18e-06 | 11 | 45 | 3 | CID000484683 | |
| Drug | manidipine | 1.22e-06 | 95 | 45 | 5 | CID000004008 | |
| Drug | AC1L2VU3 | 1.57e-06 | 12 | 45 | 3 | CID000129572 | |
| Drug | isradipine | 1.57e-06 | 100 | 45 | 5 | CID000003784 | |
| Drug | gadolinium | 2.54e-06 | 199 | 45 | 6 | CID000023982 | |
| Drug | butamben | 3.23e-06 | 15 | 45 | 3 | CID000002482 | |
| Drug | lamotrigine | 3.27e-06 | 116 | 45 | 5 | CID000003878 | |
| Drug | norcepharadione B | 3.82e-06 | 2 | 45 | 2 | CID000189168 | |
| Drug | aristolactam AII | 3.82e-06 | 2 | 45 | 2 | CID000148657 | |
| Drug | alkosin | 3.82e-06 | 2 | 45 | 2 | CID005488638 | |
| Drug | piperolactam A | 3.82e-06 | 2 | 45 | 2 | CID003081016 | |
| Drug | pentasulfane | 3.97e-06 | 16 | 45 | 3 | CID000448216 | |
| Drug | phenytoin | 4.40e-06 | 219 | 45 | 6 | CID000001775 | |
| Drug | Cinildipine | 4.54e-06 | 56 | 45 | 4 | CID000002752 | |
| Drug | bepridil | 4.90e-06 | 126 | 45 | 5 | CID000002351 | |
| Drug | nilvadipine | 5.99e-06 | 60 | 45 | 4 | CID000004494 | |
| Drug | IAA-94 | 6.40e-06 | 61 | 45 | 4 | CID000003667 | |
| Drug | N6-Me-dAdo | 6.84e-06 | 19 | 45 | 3 | CID000168948 | |
| Drug | pranidipine | 6.84e-06 | 19 | 45 | 3 | CID006436048 | |
| Drug | lercanidipine | 7.28e-06 | 63 | 45 | 4 | CID000065866 | |
| Drug | isovalerate | 9.09e-06 | 143 | 45 | 5 | CID000010430 | |
| Drug | gallopamil | 9.32e-06 | 67 | 45 | 4 | CID000001234 | |
| Drug | AC1L2AC7 | 1.05e-05 | 69 | 45 | 4 | CID000068733 | |
| Drug | barium | 1.07e-05 | 148 | 45 | 5 | CID000104810 | |
| Drug | LY320135 | 1.24e-05 | 23 | 45 | 3 | CID005311257 | |
| Drug | alpha-conotoxin SI | 1.24e-05 | 23 | 45 | 3 | CID000163979 | |
| Drug | procaine | 1.26e-05 | 153 | 45 | 5 | CID000004914 | |
| Drug | CAS 298-57-7 | 1.31e-05 | 73 | 45 | 4 | CID000002761 | |
| Drug | ethosuximide | 1.38e-05 | 74 | 45 | 4 | CID000003291 | |
| Drug | glufosinate | 1.54e-05 | 76 | 45 | 4 | CID000004794 | |
| Drug | nisoldipine | 1.71e-05 | 78 | 45 | 4 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.80e-05 | 79 | 45 | 4 | CID005287890 | |
| Drug | gabapentin | 2.04e-05 | 169 | 45 | 5 | CID000003446 | |
| Drug | mAHP | 2.04e-05 | 27 | 45 | 3 | CID000220531 | |
| Drug | eniluracil | 2.04e-05 | 27 | 45 | 3 | CID000043157 | |
| Drug | lavendustin A | 2.16e-05 | 171 | 45 | 5 | CID000003894 | |
| Drug | 2,3,4,6-Tetrachloroanisole | 2.29e-05 | 4 | 45 | 2 | CID000013647 | |
| Drug | NSC7524 | 2.91e-05 | 182 | 45 | 5 | CID000005657 | |
| Drug | 2-amino-4-phosphonobutyric acid | 3.14e-05 | 91 | 45 | 4 | CID000002207 | |
| Drug | DAPs | 3.28e-05 | 92 | 45 | 4 | CID000146339 | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; HL60; HG-U133A | 3.40e-05 | 188 | 45 | 5 | 2000_UP | |
| Drug | 3-aminopropylphosphinic acid | 3.44e-05 | 32 | 45 | 3 | CID006335948 | |
| Drug | almagel | 3.81e-05 | 5 | 45 | 2 | CID003080942 | |
| Drug | S 8510 | 3.81e-05 | 5 | 45 | 2 | CID005488383 | |
| Drug | dihydropyridine | 3.86e-05 | 193 | 45 | 5 | CID000104822 | |
| Drug | isotetrandrine | 4.03e-05 | 97 | 45 | 4 | CID000005422 | |
| Drug | fluspirilene | 4.14e-05 | 34 | 45 | 3 | CID000003396 | |
| Drug | nitrendipine | 4.20e-05 | 98 | 45 | 4 | CID000004507 | |
| Drug | 3-7a | 4.92e-05 | 36 | 45 | 3 | CID011987860 | |
| Drug | CP-80 | 4.92e-05 | 36 | 45 | 3 | CID000452640 | |
| Drug | sipatrigine | 5.35e-05 | 37 | 45 | 3 | CID000060803 | |
| Drug | loperamide | 5.50e-05 | 105 | 45 | 4 | CID000003954 | |
| Drug | AC1Q7BER | 5.70e-05 | 6 | 45 | 2 | CID000005702 | |
| Drug | 8-cyclopentyltheophylline | 5.80e-05 | 38 | 45 | 3 | CID000001917 | |
| Drug | 3,4-diaminopyridine | 5.80e-05 | 38 | 45 | 3 | CID000005918 | |
| Drug | H S Q | 6.31e-05 | 351 | 45 | 6 | CID000000897 | |
| Drug | AC1L1I54 | 7.30e-05 | 41 | 45 | 3 | CID000004426 | |
| Drug | Fk 888 | 7.85e-05 | 42 | 45 | 3 | CID000107967 | |
| Drug | AC1NBU2S | 8.39e-05 | 117 | 45 | 4 | CID004473765 | |
| Drug | valproate | 9.91e-05 | 381 | 45 | 6 | CID000003121 | |
| Drug | pimozide | 1.15e-04 | 127 | 45 | 4 | CID000016362 | |
| Drug | m-7a | 1.36e-04 | 9 | 45 | 2 | CID000029558 | |
| Drug | lanthanum | 1.50e-04 | 136 | 45 | 4 | CID000023926 | |
| Drug | 4-AP | 1.52e-04 | 258 | 45 | 5 | CID000001727 | |
| Drug | smilageninoside | 1.70e-04 | 10 | 45 | 2 | CID000197391 | |
| Drug | benzyl-EDTA | 1.70e-04 | 10 | 45 | 2 | CID000129213 | |
| Drug | nefiracetam | 1.86e-04 | 56 | 45 | 3 | CID000071157 | |
| Drug | Dantrolene-13C3 | 1.92e-04 | 145 | 45 | 4 | CID000002951 | |
| Drug | nimodipine | 1.92e-04 | 145 | 45 | 4 | CID000004497 | |
| Drug | nicardipine | 1.92e-04 | 145 | 45 | 4 | CID000004473 | |
| Drug | BAPNA | 1.96e-04 | 57 | 45 | 3 | CID000013494 | |
| Drug | gastrodin | 2.08e-04 | 11 | 45 | 2 | CID000115067 | |
| Drug | 4-aminopiperidine | 2.08e-04 | 11 | 45 | 2 | CID000424361 | |
| Drug | etorphine | 2.17e-04 | 59 | 45 | 3 | CID000026721 | |
| Drug | Bay K 8644 | 2.19e-04 | 150 | 45 | 4 | CID000002303 | |
| Drug | U46619 | 2.41e-04 | 285 | 45 | 5 | CID000005618 | |
| Drug | isobutanol | 2.51e-04 | 62 | 45 | 3 | CID000006560 | |
| Drug | EGTA-AM | 2.51e-04 | 62 | 45 | 3 | CID000121907 | |
| Drug | mibefradil | 2.76e-04 | 64 | 45 | 3 | CID000060662 | |
| Drug | AC1L1DXE | 3.00e-04 | 299 | 45 | 5 | CID000002548 | |
| Drug | AC1L1TJF | 3.03e-04 | 66 | 45 | 3 | CID000003377 | |
| Drug | DCG-IV | 3.31e-04 | 68 | 45 | 3 | CID000115114 | |
| Drug | AC1L1JG6 | 3.42e-04 | 14 | 45 | 2 | CID000005026 | |
| Drug | felodipine | 3.44e-04 | 169 | 45 | 4 | CID000003333 | |
| Drug | synthetic pyrethrins | 3.75e-04 | 71 | 45 | 3 | CID000002982 | |
| Drug | flecainide | 3.75e-04 | 71 | 45 | 3 | CID000003355 | |
| Drug | verapamil | 3.85e-04 | 490 | 45 | 6 | CID000002520 | |
| Drug | Barium | 3.91e-04 | 72 | 45 | 3 | ctd:D001464 | |
| Drug | papaverine | 4.01e-04 | 176 | 45 | 4 | CID000004680 | |
| Drug | MK-677 | 4.07e-04 | 73 | 45 | 3 | CID000178024 | |
| Drug | 1,3-dipropylxanthine | 4.24e-04 | 74 | 45 | 3 | CID000169317 | |
| Drug | DM-nitrophen | 4.50e-04 | 16 | 45 | 2 | CID000003083 | |
| Drug | Verapamil | 4.50e-04 | 16 | 45 | 2 | DB00661 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 3.31e-09 | 3 | 45 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.32e-08 | 4 | 45 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.16e-07 | 7 | 45 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.77e-07 | 163 | 45 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | colon cancer (implicated_via_orthology) | 1.24e-04 | 11 | 45 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 1.49e-04 | 12 | 45 | 2 | C0270960 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.76e-04 | 13 | 45 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 2.05e-04 | 14 | 45 | 2 | EFO_0020941 | |
| Disease | respiratory quotient | 2.05e-04 | 14 | 45 | 2 | EFO_0005189 | |
| Disease | Tremor, Rubral | 2.69e-04 | 16 | 45 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.69e-04 | 16 | 45 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.69e-04 | 16 | 45 | 2 | C0278161 | |
| Disease | Abnormal coordination | 2.69e-04 | 16 | 45 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.69e-04 | 16 | 45 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 2.69e-04 | 16 | 45 | 2 | C0240991 | |
| Disease | Ataxia | 6.67e-04 | 25 | 45 | 2 | C0004134 | |
| Disease | creatinine measurement | 7.19e-04 | 995 | 45 | 7 | EFO_0004518 | |
| Disease | Epileptic encephalopathy | 9.63e-04 | 30 | 45 | 2 | C0543888 | |
| Disease | Papillary Renal Cell Carcinoma | 9.90e-04 | 128 | 45 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 9.90e-04 | 128 | 45 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 9.90e-04 | 128 | 45 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 9.90e-04 | 128 | 45 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 9.90e-04 | 128 | 45 | 3 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.50e-03 | 148 | 45 | 3 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NWNYFGWGEQHNDDP | 176 | Q9UPW8 | |
| NSNDASGNTWNWLYF | 326 | O00555 | |
| FATDWSQQPGLNWYA | 251 | P60509 | |
| VANSWNTDWGDNGFF | 296 | P07858 | |
| YNTNDALGATWNWLY | 316 | Q15878 | |
| VNGFSNNYWGWGGED | 246 | O60513 | |
| AFWDFENNNGLGGWN | 2686 | Q8IZF6 | |
| EAQNTTYLWWVNGQS | 526 | P06731 | |
| NEKWAYNNSDGGTAW | 91 | O00273 | |
| YNTNDAAGNTWNWLY | 321 | Q00975 | |
| LNYLNWKQSGGTEWT | 326 | Q9Y222 | |
| KYFLNGGWTIQWNGD | 746 | Q9UKP4 | |
| GGWTIQWNGDYQVAG | 751 | Q9UKP4 | |
| VGTWNTWYGEQDQAV | 111 | O75323 | |
| VDWIGNNLYWTNDGH | 606 | Q9NZR2 | |
| NAWVAGSYGNDQWLQ | 276 | Q08431 | |
| NVQCDWQQKGGTYWV | 2606 | O95714 | |
| NGSWAAGYGIWNTAI | 431 | Q5FYB0 | |
| NWRLGQAPANWYNDT | 76 | Q8WVQ1 | |
| GQWANLSWELLYATN | 1116 | Q63HM2 | |
| GVAITGNQTFNNWNW | 71 | O95279 | |
| QGWGSTYQAWQQPTQ | 486 | Q96I24 | |
| QQGQFWGQKPWSQHY | 806 | Q00839 | |
| WNNQAWNSPFYNCGE | 231 | Q9H9S0 | |
| LVWQDNTAVNYSNWG | 1341 | Q9UBG0 | |
| AWSLLDNFEWNQGYS | 416 | Q9H227 | |
| GWWYNNCQAANLNGI | 806 | P02671 | |
| AWNNYKGYAWGLNEL | 206 | P33908 | |
| GWSRYWISGNAANGQ | 71 | Q6UWL6 | |
| QQGGHYSLQVDWYTW | 1656 | Q9BYK8 | |
| VDSYQSWALAGGWNS | 166 | Q92826 | |
| WAFDKIQNNWSYGEN | 2766 | P21817 | |
| NWNTWYGEQDQAVHL | 111 | Q9BPW8 | |
| SNDTWYGNDTWYGNE | 296 | P35499 | |
| IQCQNKGWDGYDVQW | 81 | Q96BY9 | |
| WNNQAWNSPFYNCGE | 231 | Q6NSW7 | |
| NLDNLAQLYEGWTAW | 3646 | Q96Q15 | |
| HLSYANGINWAQWKG | 226 | P55083 | |
| TWQGVEEGWGGYNNT | 2741 | P08F94 | |
| SYAQSQGWWTGEGEF | 206 | Q12765 | |
| FWNFRLANNTGGWDS | 956 | Q8IZF2 | |
| WNKLLNWYGCVEGQQ | 101 | Q13107 | |
| GGNGQVFSNWAQFWL | 126 | Q96N76 | |
| SQWGQWSQVYGNPQQ | 291 | Q01085 | |
| FTWGNNINPNNSSGW | 896 | Q8NDV7 | |
| YGQWGQWYGNAQQIG | 306 | P31483 | |
| GGWNDYKNNNSSNWG | 696 | Q9UPQ9 | |
| WGDPNSYNYKNVNLW | 896 | Q9UPQ9 |